The government held a meeting of the Public-Private Council’s Subcommittee for Consideration and Promotion of Measures to strengthen drug discovery capabilities on 30 October, where it discussed domestic manufacturing of pharmaceuticals and support for reinvestment. This was the 3rd of 4 meetings, and the topic was added to the agenda following input from council members.
The government discussed manufacturing and domestic investment at the meeting of the Public-Private Council’s Subcommittee for Consideration and Promotion of Measures to strengthen drug discovery capabilities, held on 30 October. The purpose of this article is to give concrete form to the main measures under consideration by the subcommittee and the policy package that should be implemented.
The agenda item was not originally included in the topics, but was added after members said that manufacturing and domestic investment were also important. This was the 3rd of 4 meetings.